United States Multiplex Assay Market Forecast 2024-2032

The United States multiplex assay market is set to record a CAGR of 8.01% during the forecast period, 2024-2032. The market growth is attributed to advancements in technology and increased demand for efficient diagnostic solutions.

MARKET INSIGHTS

The distinct advantages of multiplex assays over singleplex and conventional assays are propelling the US market growth. Multiplex assays provide various benefits, including sample consumption reduction through miniaturization, enhanced operational efficiency, simplified operations, and decreased labor costs. These factors collectively contribute to the rising prevalence of Multiplex Assays in the United States.

Whereas the increasing need for healthcare systems to offer services at affordable rates is anticipated to impede the expansion of the Multiplex Assays Market. Nonetheless, the inherent value of multiplexed assay products and services in furnishing comprehensive and effective healthcare information indicates that the market holds promising long-term potential.

Nonetheless, the United States multiplex assay market is poised for continued growth, fueled by technological advancements, expanding applications across diverse sectors, and increasing adoption by healthcare professionals seeking more efficient diagnostic tools to improve patient care.

COMPETITIVE INSIGHTS

Some of the leading players in the market include Becton, Dickinson and Company (BD), Agilent Technologies Inc, Bio-Rad Laboratories Inc, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
COUNTRY ANALYSIS
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
- 2.5.1. SOFTWARE AND SERVICES SECTOR EMERGES AS THE RAPIDLY EXPANDING PRODUCT & SERVICE SEGMENT
- 2.5.2. PROTEIN-BASED MULTIPLEX ASSAY IS THE HIGHEST REVENUE-GENERATING TYPE
- 2.5.3. RESEARCH & DEVELOPMENT APPLICATIONS DOMINATE MARKET SHARE
- 2.5.4. MULTIPLEX PCR TECHNOLOGY DEMONSTRATES FASTER GROWTH
- 2.5.5. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES ARE MAJOR USERS OF MULTIPLEX ASSAYS

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. ESCALATING INCIDENCE OF CHRONIC DISEASES
- 3.1.2. GROWING PREFERENCE FOR MULTIPLEX ASSAYS OVER CONVENTIONAL APPROACHES
- 3.1.3. INCREASING ACCEPTANCE OF PERSONALIZED MEDICINE
3.2. KEY RESTRAINTS
- 3.2.1. OVERCOMING THE DIFFICULTY OF ESTABLISHING SUFFICIENT ASSAY RANGE
- 3.2.2. CHALLENGES ASSOCIATED WITH CROSS-REACTIVITY AND ASSAY INTERFERENCE
- 3.2.3. SHORTAGE OF SKILLED PROFESSIONALS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. RISING DRUG DISCOVERY ENDEAVORS
- 4.1.2. PROGRESS IN ASSAY PLATFORM TECHNOLOGY
- 4.1.3. RAPID EXPANSION OF COMPANION DIAGNOSTICS
4.2. PESTLE ANALYSIS
- 4.2.1. POLITICAL
- 4.2.2. ECONOMICAL
- 4.2.3. SOCIAL
- 4.2.4. TECHNOLOGICAL
- 4.2.5. LEGAL
- 4.2.6. ENVIRONMENTAL
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. MARKET CONCENTRATION ANALYSIS
4.5. KEY BUYING CRITERIA
- 4.5.1. COVERAGE OF ANALYTES
- 4.5.2. RAPIDITY
- 4.5.3. ABILITY TO MULTIPLEX
- 4.5.4. USER-FRIENDLINESS
- 4.5.5. AUTOMATION POTENTIAL
4.6. VALUE CHAIN ANALYSIS
- 4.6.1. RESEARCH AND DEVELOPMENT (R&D)
- 4.6.2. MANUFACTURING AND PRODUCTION
- 4.6.3. DISTRIBUTION AND SUPPLY CHAIN
- 4.6.4. CLINICAL APPLICATION AND DATA ANALYSIS
- 4.6.5. MARKET RESEARCH AND COMMERCIALIZATION

5. MARKET BY PRODUCT AND SERVICE

5.1. REAGENTS AND CONSUMABLES
- 5.1.1. MARKET FORECAST FIGURE
- 5.1.2. SEGMENT ANALYSIS
5.2. INSTRUMENTS AND ACCESSORIES
- 5.2.1. MARKET FORECAST FIGURE
- 5.2.2. SEGMENT ANALYSIS
5.3. SOFTWARE AND SERVICES
- 5.3.1. MARKET FORECAST FIGURE
- 5.3.2. SEGMENT ANALYSIS

6. MARKET BY TYPE

6.1. PROTEIN-BASED MULTIPLEX ASSAY
- 6.1.1. MARKET FORECAST FIGURE
- 6.1.2. SEGMENT ANALYSIS
6.2. NUCLEIC ACID-BASED MULTIPLEX ASSAY
- 6.2.1. MARKET FORECAST FIGURE
- 6.2.2. SEGMENT ANALYSIS
6.3. OTHER TYPES
- 6.3.1. MARKET FORECAST FIGURE
- 6.3.2. SEGMENT ANALYSIS

7. MARKET BY APPLICATION

7.1. RESEARCH AND DEVELOPMENT
- 7.1.1. MARKET FORECAST FIGURE
- 7.1.2. SEGMENT ANALYSIS
7.2. CLINICAL DIAGNOSTICS
- 7.2.1. MARKET FORECAST FIGURE
- 7.2.2. SEGMENT ANALYSIS
7.3. COMPANION DIAGNOSTICS
- 7.3.1. MARKET FORECAST FIGURE
- 7.3.2. SEGMENT ANALYSIS

8. MARKET BY TECHNOLOGY

8.1. MULTIPLEX PROTEIN MICROARRAY
- 8.1.1. MARKET FORECAST FIGURE
- 8.1.2. SEGMENT ANALYSIS
8.2. MULTIPLEX PCR
- 8.2.1. MARKET FORECAST FIGURE
- 8.2.2. SEGMENT ANALYSIS
8.3. OTHER TECHNOLOGIES
- 8.3.1. MARKET FORECAST FIGURE
- 8.3.2. SEGMENT ANALYSIS

9. MARKET BY END-USER

9.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 9.1.1. MARKET FORECAST FIGURE
- 9.1.2. SEGMENT ANALYSIS
9.2. RESEARCH INSTITUTES
- 9.2.1. MARKET FORECAST FIGURE
- 9.2.2. SEGMENT ANALYSIS
9.3. CLINICAL LABORATORIES
- 9.3.1. MARKET FORECAST FIGURE
- 9.3.2. SEGMENT ANALYSIS
9.4. HOSPITALS
- 9.4.1. MARKET FORECAST FIGURE
- 9.4.2. SEGMENT ANALYSIS

10. COMPETITIVE LANDSCAPE

10.1. KEY STRATEGIC DEVELOPMENTS
- 10.1.1. MERGERS & ACQUISITIONS
- 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 10.1.3. PARTNERSHIPS & AGREEMENTS
- 10.1.4. BUSINESS EXPANSIONS & DIVESTITURES
10.2. COMPANY PROFILES
- 10.2.1. AGILENT TECHNOLOGIES INC
  - 10.2.1.1. COMPANY OVERVIEW
  - 10.2.1.2. PRODUCT PORTFOLIO
  - 10.2.1.3. STRENGTHS & CHALLENGES
- 10.2.2. BECTON, DICKINSON AND COMPANY (BD)
  - 10.2.2.1. COMPANY OVERVIEW
  - 10.2.2.2. PRODUCT PORTFOLIO
  - 10.2.2.3. STRENGTHS & CHALLENGES
- 10.2.3. BIO-RAD LABORATORIES INC
  - 10.2.3.1. COMPANY OVERVIEW
  - 10.2.3.2. PRODUCT PORTFOLIO
  - 10.2.3.3. STRENGTHS & CHALLENGES
- 10.2.4. BIO-TECHNE CORPORATION
  - 10.2.4.1. COMPANY OVERVIEW
  - 10.2.4.2. PRODUCT PORTFOLIO
- 10.2.5. ILLUMINA INC
  - 10.2.5.1. COMPANY OVERVIEW
  - 10.2.5.2. PRODUCT PORTFOLIO
  - 10.2.5.3. STRENGTHS & CHALLENGES
- 10.2.6. MERCK MILLIPORE
  - 10.2.6.1. COMPANY OVERVIEW
  - 10.2.6.2. PRODUCT PORTFOLIO
- 10.2.7. THERMO FISHER SCIENTIFIC INC
  - 10.2.7.1. COMPANY OVERVIEW
  - 10.2.7.2. PRODUCT PORTFOLIO
  - 10.2.7.3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - WOOD BASED PANEL
TABLE 2: UNITED STATES MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: UNITED STATES MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: UNITED STATES MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: UNITED STATES MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: UNITED STATES MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: UNITED STATES MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: UNITED STATES MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: UNITED STATES MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: UNITED STATES MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: UNITED STATES MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: LIST OF MERGERS & ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: MARKET CONCENTRATION ANALYSIS
FIGURE 4: KEY BUYING CRITERIA
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: UNITED STATES MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY PRODUCT AND SERVICE, IN 2023
FIGURE 7: UNITED STATES MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2024-2032 (IN $ MILLION)
FIGURE 8: UNITED STATES MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2024-2032 (IN $ MILLION)
FIGURE 9: UNITED STATES MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2024-2032 (IN $ MILLION)
FIGURE 10: UNITED STATES MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023
FIGURE 11: UNITED STATES MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2024-2032 (IN $ MILLION)
FIGURE 12: UNITED STATES MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2024-2032 (IN $ MILLION)
FIGURE 13: UNITED STATES MULTIPLEX ASSAY MARKET, BY OTHER TYPES, 2024-2032 (IN $ MILLION)
FIGURE 14: UNITED STATES MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023
FIGURE 15: UNITED STATES MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2024-2032 (IN $ MILLION)
FIGURE 16: UNITED STATES MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2024-2032 (IN $ MILLION)
FIGURE 17: UNITED STATES MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2024-2032 (IN $ MILLION)
FIGURE 18: UNITED STATES MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2023
FIGURE 19: UNITED STATES MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2024-2032 (IN $ MILLION)
FIGURE 20: UNITED STATES MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2024-2032 (IN $ MILLION)
FIGURE 21: UNITED STATES MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2024-2032 (IN $ MILLION)
FIGURE 22: UNITED STATES MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY END-USER, IN 2023
FIGURE 23: UNITED STATES MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2024-2032 (IN $ MILLION)
FIGURE 24: UNITED STATES MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2024-2032 (IN $ MILLION)
FIGURE 25: UNITED STATES MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2024-2032 (IN $ MILLION)
FIGURE 26: UNITED STATES MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)